C4 IMAGING, LLC

BELLAIRE, TX · Founded 2009 · CIK 0001481933 · Medtech · Private

MRI/CT markers for radioactive seed localization and treatment assessment in prostate brachytherapy

c4imaging.com →
Grants
$2.0M
2 awards
Sector median: 1
Raised
$6.0M
5 Form D · Mar 2024
31 months since last filing
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$1,450,000
Private capital raisedForm D · SEC$1,205,000
Federal grantDepartment of Health and Human Services · Phase II · Multi-Modality MRI/CT Markers for Improved Assessment of Prostate Cancer$1,314,320
Federal grantDepartment of Health and Human Services · Phase II · Multi-Modality MRI/CT Markers for Improved Assessment of Prostate Cancer$640,660
Private capital raisedForm D · SEC$1,100,000
Private capital raisedForm D · SEC$1,200,000
Private capital raisedForm D · SEC$1,031,272
Federal grant · SBIR/STTRForm D · SEC

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
915CREATHADH ENERGIES, LLC——
916ORTHOCARE INNOVATIONS, LLC—$6.0M
917Hinge Bio, Inc.—$59M
918C4 IMAGING, LLC—$6.0M
919Granite Medical, LLC——
920LungLife AI, Inc.—$53M
921BIOCHIP LABS, INC.——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 5 related persons
  • Andrew BrightExecutive Officer
  • Steven FrankDirector · Executive Officer
  • Harry MaziarDirector
  • Jeff SeaveyDirector
  • Steven SheldonDirector

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.